跳至主要内容
临床试验/NCT05758987
NCT05758987招募中不适用

Evaluation of Blended CBT for PTSD in Regular Care: A New Format of Computer-Assisted Trauma-Focused Cognitive Behavioral Therapy: A Randomized Controlled Non-inferiority Trial

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2023年3月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
160
试验地点
2
主要终点
The Posttraumatic stress disorder checklist 5 (PCL-5)

研究概览

简要总结

A Randomized Controlled Non-inferiority Trial testing if the new experimental Blended Trauma focused cognitive behavioral therapy (B-TF-CBT) for post traumatic stress disorder (PTSD), is non-inferior to gold standard control treatment Prolonged Exposure (PE).

Research question and hypothesis

Primary

  1. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 post-treatment?

Secondary: 2. Is bTF-CT non-inferior to prolonged exposure (PE) when delivered in routine clinical care in terms of PTSD symptoms on the PCL-5 at 6 and 12 months follow up? 3. Are there significant differences between bTF-CT and PE when delivered in routine clinical care in terms of depression, anxiety, insomnia, functionality, complex PTSD, other PTSD-measures and treatment satisfaction post-treatment and at 6 and 12 months follow up?

The study will be conducted at 3-6 outpatient clinics in Region Stockholm, Sweden.

详细描述

To study effects, the investigators aim to conduct a randomized controlled trial (RCT) comparing blended treatment to an evidence-based face-to-face TF-CBT protocol, Prolonged exposure.

Data will be collected concerning symptoms of PTSD with the PTSD Checklist for Diagnostic and Statistical Manual 5 (DSM-5; PCL-5) which will be the primary outcome measure. Further, symptoms of PTSD will be measured with Clinician-administered PTSD Scale for DSM-5 (CAPS-5), depression The PHQ-9, symptoms of anxiety with GAD-7 , quality of life with Work and social adjustment scale (WSAS), and sleep with the insomnia severity index (ISI). Outcome measures will be distributed before, during, after, as well as 12-months following treatment.

In accordance with CONSORT recommendations for non-inferiority trials, both intention-to-treat (ITT) and per-protocol (PP) analyses will be performed and reported for the primary non-inferiority comparisons. Secondary outcomes will be analyzed using ITT principles.

ITT population All randomized participants who completed the pre-treatment assessment and participated in the inclusion session.

PP population The PP population will include participants who have received at least 50% of the planned total treatment dose, defined across both digital modules and face-to-face sessions in the blended format.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Assessor of secondary outcome CAPS will be masked to participant allocation at post and follow-up assessments.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •PTSD according to Diagnostic and Statistical Manual of mental disorders 5 as primary problem
  • •≥ 18 years
  • •Basic knowledge of speaking and writing Swedish
  • •No other psychological treatment at the same time
  • •No ongoing threats or violence
  • •If antidepressant medication, stable dose 6 weeks before starting treatment
  • •Have access to the internet and a computer
  • •Willingness/ability to participate after receiving information about what participation entails

排除标准

  • •Other diagnosis or problem is assessed as primary to PTSD
  • •Moderate to severe suicidal risk
  • •PTSD from childhood trauma that the person cannot remember

研究组 & 干预措施

Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT)

Experimental

B-Tf-CBT shares key features with Internet-based CBT (I-CBT) in that it is based on a digital support accessible to the patient. This digital support equips blended treatment with the same proposed advantages as I-CBT in terms of improving treatment accessibility, adherence, and reducing therapist-time. In addition, incorporating 6 biweekly face-to-face sessions to facilitate and augment delivery of more demanding components of TF-CBT such as memory exposure.

干预措施: Blended Trauma focused Cognitive Behavioral Therapy (B-Tf-CBT) (Behavioral)

Prolonged exposure

Active Comparator

Gold standard Tf-CBT Prolonged exposure will constitute the control condition. Prolonged exposure will be delivered by trained therapists under supervision adhering to the evidence based manual delivered face-to-face over 9-15 weeks.

干预措施: Prolonged exposure (Behavioral)

结局指标

主要结局

The Posttraumatic stress disorder checklist 5 (PCL-5)

时间窗: Change from pre intervention to 12 months post intervention

Self rated PTSD-symptoms. Minimum value 0, maximum value 80, where higher values indicate more PTSD symptoms.

The Posttraumatic stress disorder checklist 5 (PCL-5)

时间窗: Change from pre intervention to immediately post intervention

Self rated PTSD-symptoms. Minimum value 0, maximum value 80, where higher values indicate more PTSD symptoms.

The Posttraumatic stress disorder checklist 5 (PCL-5)

时间窗: Change from pre intervention to 6 months post intervention

Self rated PTSD-symptoms. Minimum value 0, maximum value 80, where higher values indicate more PTSD symptoms.

次要结局

  • EUROQOL 5 dimensions (EQ5D)(Change from pre intervention to 12 months post intervention)
  • Questions about work situation(12 months post intervention)
  • Registry data for the cost-effectiveness analysis(During the 12 month period post intervention)
  • Posttraumatic cognitions inventory (PTCI)(12 months post intervention)
  • The Response to Intrusions Questionnaire (RIQ)(12 months post intervention)
  • The internet intervention Patient Adherence Scale (iiPAS)(Immediately post intervention)
  • Client Satisfaction Questionnaire (CSQ-8)(Immediately post intervention)
  • Negative Effects Questionnaire (NEQ)(Immediately post intervention)
  • Clinician-administered PTSD Scale for DSM-5 (CAPS-5)(12 months post intervention)
  • Patient Health Questionnaire (PHQ-9)(Change from pre intervention to 12 months post intervention)
  • Generalized Anxiety Disorder 7-item scale (GAD-7)(Change from pre intervention to 12 months post intervention)
  • Insomnia Severity Index (ISI)(Change from pre intervention to 12 months post intervention)
  • The Work and Social Adjustment Scale (WSAS)(Change from pre intervention to 12 months post intervention)
  • credibility/expectancy questionnaire(Two weeks post intervention start)
  • Clinician-administered PTSD Scale for DSM-5 (CAPS-5)(12 months post intervention)
  • Questions about work situation(12 months post intervention)
  • Patient Health Questionnaire (PHQ-9)(Change from pre intervention to 12 months post intervention)
  • Generalized Anxiety Disorder 7-item scale (GAD-7)(Change from pre intervention to 12 months post intervention)
  • Insomnia Severity Index (ISI)(Change from pre intervention to 12 months post intervention)
  • The Work and Social Adjustment Scale (WSAS)(Change from pre intervention to 12 months post intervention)
  • EUROQOL 5 dimensions (EQ5D)(Change from pre intervention to 12 months post intervention)
  • Registry data for the cost-effectiveness analysis(During the 12 month period post intervention)
  • Posttraumatic cognitions inventory (PTCI)(12 months post intervention)
  • The Response to Intrusions Questionnaire (RIQ)(12 months post intervention)
  • The internet intervention Patient Adherence Scale (iiPAS)(Immediately post intervention)
  • International Trauma Questionnaire(12 months post intervention for participants included 2025)
  • Client Satisfaction Questionnaire (CSQ-8)(Immediately post intervention)
  • Negative Effects Questionnaire (NEQ)(Immediately post intervention)
  • credibility/expectancy questionnaire(Two weeks post intervention start)
  • Autonomy, Flexibility, and Alliance Scale (study-specific measure)(6 months post intervention for participants included 2025)
  • Clinician-administered PTSD Scale for DSM-5 (CAPS-5)(1 week post intervention)
  • Patient Health Questionnaire (PHQ-9)(Change from pre intervention to immediately post intervention)
  • The Work and Social Adjustment Scale (WSAS)(Change from pre intervention to immediately post intervention)
  • Patient Health Questionnaire (PHQ-9)(Change from pre intervention to 6 months post intervention)
  • Generalized Anxiety Disorder 7-item scale (GAD-7)(Change from pre intervention to immediately post intervention)
  • Generalized Anxiety Disorder 7-item scale (GAD-7)(Change from pre intervention to 6 months post intervention)
  • Insomnia Severity Index (ISI)(Change from pre intervention to immediately post intervention)
  • Insomnia Severity Index (ISI)(Change from pre intervention to 6 months post intervention)
  • The Work and Social Adjustment Scale (WSAS)(Change from pre intervention to 6 months post intervention)
  • EUROQOL 5 dimensions (EQ5D)(Change from pre intervention to immediately post intervention)
  • EUROQOL 5 dimensions (EQ5D)(Change from pre intervention to 6 months post intervention)
  • Questions about work situation(Pre intervention)
  • Questions about work situation(6 months post intervention)
  • Posttraumatic cognitions inventory (PTCI)(Pre intervention)
  • Posttraumatic cognitions inventory (PTCI)(6 weeks post intervention start)
  • Posttraumatic cognitions inventory (PTCI)(immediately post intervention)
  • Posttraumatic cognitions inventory (PTCI)(6 months post intervention)
  • The Response to Intrusions Questionnaire (RIQ)(Pre intervention)
  • The Response to Intrusions Questionnaire (RIQ)(6 weeks post intervention start)
  • The Response to Intrusions Questionnaire (RIQ)(Immediately post intervention)
  • The Response to Intrusions Questionnaire (RIQ)(6 months post intervention)
  • The internet intervention Patient Adherence Scale (iiPAS)(6 weeks post intervention start)
  • International Trauma Questionnaire(Pre intervention for participants included 2025)
  • International Trauma Questionnaire(Immediately post intervention for participants included 2025)
  • International Trauma Questionnaire(6 months post intervention for participants included 2025)
  • Autonomy, Flexibility, and Alliance Scale (study-specific measure)(Immediately post intervention for participants included 2025)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sigrid Salomonsson

Principal investigator, PhD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验